Braun Lipoprotein (Lpp) Contributes to Virulence of Yersiniae: Potential Role of Lpp in Inducing Bubonic and Pneumonic Plague
暂无分享,去创建一个
W. Baze | J. Peterson | J. Sha | G. Suarez | T. E. Erova | A. Chopra | V. Motin | Shao-kai Wang | J. Olano | A. A. Fadl | G. Klimpel | Sadhana Chauhan | S. M. Foltz | S. Agar | Shao-Kai Wang | Stacy L. Agar | Sheri M. Foltz
[1] J. Sha,et al. Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines. , 2008, Microbial pathogenesis.
[2] Andrey P. Anisimov,et al. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. , 2007, Vaccine.
[3] J. Frey. Biological safety concepts of genetically modified live bacterial vaccines. , 2007, Vaccine.
[4] D. Goodlett,et al. Identification and type III‐dependent secretion of the Yersinia pestis insecticidal‐like proteins , 2007, Molecular Microbiology.
[5] W. Baze,et al. Human Monoclonal Antibody AVP-21D9 to Protective Antigen Reduces Dissemination of the Bacillus anthracis Ames Strain from the Lungs in a Rabbit Model , 2007, Infection and Immunity.
[6] Shixia Wang,et al. Evaluation of the Role of LcrV-Toll-Like Receptor 2-Mediated Immunomodulation in the Virulence of Yersinia pestis , 2007, Infection and Immunity.
[7] B. J. Hinnebusch,et al. Oral Vaccination with Salmonella Simultaneously Expressing Yersinia pestis F1 and V Antigens Protects against Bubonic and Pneumonic Plague1 , 2007, The Journal of Immunology.
[8] M. Bewernitz,et al. CENTER FOR DRUG EVALUATION AND RESEARCH , 2007 .
[9] H. Flick-Smith,et al. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. , 2007, Microbial pathogenesis.
[10] A. Philipovskiy,et al. Vaccination with Live Yersinia pestis Primes CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary Y. pestis Infection , 2006, Infection and Immunity.
[11] S. Crosby,et al. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague , 2006, Proceedings of the National Academy of Sciences.
[12] L. Lindler,et al. Current trends in plague research: from genomics to virulence. , 2006, Clinical medicine & research.
[13] O. Schneewind,et al. Immunogenicity and Protective Immunity against Bubonic Plague and Pneumonic Plague by Immunization of Mice with the Recombinant V10 Antigen, a Variant of LcrV , 2006, Infection and Immunity.
[14] J. Sha,et al. Molecular and Functional Characterization of a ToxR-Regulated Lipoprotein from a Clinical Isolate of Aeromonas hydrophila , 2006, Infection and Immunity.
[15] J. Peterson,et al. Human Monoclonal Anti-Protective Antigen Antibody Completely Protects Rabbits and Is Synergistic with Ciprofloxacin in Protecting Mice and Guinea Pigs against Inhalation Anthrax , 2006, Infection and Immunity.
[16] S. Crosby,et al. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Sha,et al. Attenuation of Salmonella enterica Serovar Typhimurium by Altering Biological Functions of Murein Lipoprotein and Lipopolysaccharide , 2005, Infection and Immunity.
[18] S. Riedel. Plague: From Natural Disease to Bioterrorism , 2005, Proceedings.
[19] J. Bliska,et al. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. , 2005, Clinical immunology.
[20] J. Sha,et al. Murein Lipoprotein Is a Critical Outer Membrane Component Involved in Salmonella enterica Serovar Typhimurium Systemic Infection , 2005, Infection and Immunity.
[21] J. Bliska,et al. The Response Regulator PhoP of Yersinia pseudotuberculosis Is Important for Replication in Macrophages and for Virulence , 2004, Infection and Immunity.
[22] J. Sha,et al. The Two Murein Lipoproteins of Salmonella enterica Serovar Typhimurium Contribute to the Virulence of the Organism , 2004, Infection and Immunity.
[23] R. Titball,et al. Yersinia pestis (plague) vaccines , 2004, Expert opinion on biological therapy.
[24] C. Médigue,et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Bliska,et al. The Ability To Replicate in Macrophages Is Conserved between Yersinia pestis and Yersinia pseudotuberculosis , 2003, Infection and Immunity.
[26] Guy Plunkett,et al. Genome Sequence of Yersinia pestis KIM , 2002, Journal of bacteriology.
[27] M. Madan Babu,et al. DOLOP-database of bacterial lipoproteins , 2002, Bioinform..
[28] R. Rosqvist,et al. Role of Fraction 1 Antigen of Yersinia pestis in Inhibition of Phagocytosis , 2002, Infection and Immunity.
[29] R. Lloubès,et al. Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity. , 2002, Journal of bacteriology.
[30] Y. Doǧan,et al. Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli. , 2002, International journal of antimicrobial agents.
[31] M. Simmonds,et al. Genome sequence of Yersinia pestis, the causative agent of plague , 2001, Nature.
[32] R. Titball,et al. Vaccination against bubonic and pneumonic plague. , 2001, Vaccine.
[33] H. Wolf‐Watz,et al. YopB of Yersinia enterocolitica Is Essential for YopE Translocation , 2001, Infection and Immunity.
[34] Eduardo A. Groisman,et al. The Pleiotropic Two-Component Regulatory System PhoP-PhoQ , 2001, Journal of bacteriology.
[35] Philip K. Russell,et al. Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.
[36] B. Wren,et al. The Response Regulator PhoP Is Important for Survival under Conditions of Macrophage-Induced Stress and Virulence in Yersinia pestis , 2000, Infection and Immunity.
[37] Philip K. Russell,et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 2000, JAMA.
[38] M Achtman,et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Godowski,et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.
[40] Samuel I. Miller,et al. How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. , 1999, The Journal of infectious diseases.
[41] M. Nicol,et al. Yersiniosis II: The Pathogenesis of Yersinia Infections , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[42] G. Cornelis,et al. The Virulence Plasmid of Yersinia, an Antihost Genome , 1998, Microbiology and Molecular Biology Reviews.
[43] J. Peterson,et al. Lipoprotein Release by Bacteria: Potential Factor in Bacterial Pathogenesis , 1998, Infection and Immunity.
[44] R. Lloubès,et al. Escherichia coli tol-pal Mutants Form Outer Membrane Vesicles , 1998, Journal of bacteriology.
[45] D. Schifferli,et al. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. , 1998, Gene.
[46] J. Peterson,et al. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. , 1997, Journal of immunology.
[47] R. Perry,et al. Yersinia pestis--etiologic agent of plague , 1997, Clinical microbiology reviews.
[48] Y. Nedialkov,et al. V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague , 1996, Infection and immunity.
[49] V. L. Miller,et al. Role of RpoS in survival of Yersinia enterocolitica to a variety of environmental stresses , 1995, Journal of bacteriology.
[50] G. Cornelis,et al. MyfF, an element of the network regulating the synthesis of fibrillae in Yersinia enterocolitica , 1995, Journal of bacteriology.
[51] R. Titball,et al. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. , 1995, Vaccine.
[52] K. Gage,et al. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. , 1994, The American journal of tropical medicine and hygiene.
[53] R. Brubaker,et al. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha , 1993, Infection and immunity.
[54] B. Olsson-Liljequist. E-Test as a routine MIC tool for reference work. , 1992, Diagnostic microbiology and infectious disease.
[55] N. Duplaix. Fleas: the lethal leapers , 1988 .
[56] R. Brubaker,et al. Post-translational regulation of Lcr plasmid-mediated peptides in pesticinogenic Yersinia pestis. , 1987, Microbial pathogenesis.
[57] W. Shuford,et al. Survival and growth of Yersinia pestis within macrophages and an effect of the loss of the 47-megadalton plasmid on growth in macrophages , 1985, Infection and immunity.
[58] H. Karch,et al. Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice , 1984, Infection and immunity.
[59] S. Straley,et al. Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages , 1984, Infection and immunity.
[60] S. Straley,et al. Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants , 1984, Infection and immunity.
[61] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[62] Saltykov Ra,et al. [Experience from a 30-year study of the stability of the properties of the plague vaccine strain EV in the USSR]. , 1975 .
[63] R. A. Saltykova,et al. [Experience from a 30-year study of the stability of the properties of the plague vaccine strain EV in the USSR]. , 1975, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.
[64] V. Braun,et al. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. , 1973, European journal of biochemistry.
[65] M. Surgalla,et al. Plague Bacillus: Survival within Host Phagocytes , 1969, Science.
[66] D. C. Cavanaugh,et al. The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. , 1959, Journal of immunology.
[67] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .